Researchers develop metastasis prevention therapy based on glycan targeting

A research team led by Prof. Kenward Vong, Assistant Professor from the Department of Chemistry at The Hong Kong University of Science and Technology (HKUST) has recently achieved a significant breakthrough by bioengineering a new type of glycan-targeting system known as "lectin-directed protein aggregation therapy (LPAT)." Using this technology, they developed a therapy capable of preventing the onset and growth of metastatic breast cancers in mouse models.